Consensus of Chinese experts on the clinical management of chimeric antigen receptor T-cell-associated neurotoxicity (2022).
10.3760/cma.j.issn.0253-2727.2022.02.002
- Collective Name:Leukemia & Lymphoma Group, Chinese Society of Hematology, Chinese Medical Association;Group of Hematopoietic Stem Cell Transplantation and Cellular Therapy, Hematological Oncology Committee of China Anti-Cancer Association
- Publication Type:Journal Article
- MeSH:
China;
Consensus;
Humans;
Immunotherapy, Adoptive/adverse effects*;
Receptors, Antigen, T-Cell;
Receptors, Chimeric Antigen;
T-Lymphocytes
- From:
Chinese Journal of Hematology
2022;43(2):96-101
- CountryChina
- Language:Chinese
